Evidence map›Paper›PMID 34452061›Full record

ArticleVaccines2021

Assessing the Level and Determinants of COVID-19 Vaccine Confidence in Kenya.

Stacey Orangi, Jessie Pinchoff, Daniel Mwanga, Timothy Abuya, Mainga Hamaluba, George Warimwe, Karen Austrian, Edwine Barasa

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed, 6 pooled it
11.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 6 syntheses or guidelines pooled it, 107 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. The Role of Trust in COVID-19 Vaccine Acceptance: Considerations from a Systematic Review.International journal of environmental research and public health · 2022
    Pooled it
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. How to increase acceptance of the COVID-19 vaccine among poor people in Africa?International journal of health economics and management · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Stacey OrangiHealth Economics Research Unit (HERU), KEMRI-Wellcome Trust Research Program, Nairobi P.O. Box 43640-00100, Kenya.ORCID 0000-0002-3236-5229
Jessie PinchoffPopulation Council, New York, NY 10017, USA.
Daniel MwangaPopulation Council, Nairobi P.O. Box 17643-00500, Kenya.
Timothy AbuyaPopulation Council, Nairobi P.O. Box 17643-00500, Kenya.
Mainga HamalubaKEMRI-Wellcome Trust Research Programme, Kilifi P.O. Box 230-80108, Kenya.
George WarimweKEMRI-Wellcome Trust Research Programme, Kilifi P.O. Box 230-80108, Kenya.
Karen AustrianPopulation Council, Nairobi P.O. Box 17643-00500, Kenya.ORCID 0000-0001-5464-7908
Edwine BarasaHealth Economics Research Unit (HERU), KEMRI-Wellcome Trust Research Program, Nairobi P.O. Box 43640-00100, Kenya.
British Council · KEKenya Medical Research Institute · KEPopulation Council · USStrathmore University · KE

Funding

Innovations for Poverty Action, the University of California San Diego, the Kenya Executive Office of the President Policy and Strategy Unit, and UK Foreign Commonwealth and Development Office N/A
6 · The paper itself

Abstract

The government of Kenya has launched a phased rollout of COVID-19 vaccination. A major barrier is vaccine hesitancy; the refusal or delay of accepting vaccination. This study evaluated the level and determinants of vaccine hesitancy in Kenya. We conducted a cross-sectional study administered through a phone-based survey in February 2021 in four counties of Kenya. Multilevel logistic regression was used to identify individual perceived risks and influences, context-specific factors and vaccine-specific issues associated with COVID-19 vaccine hesitancy. COVID-19 vaccine hesitancy in Kenya was high: 36.5%. Factors associated with vaccine hesitancy included: Rural regions, perceived difficulty in adhering to government regulations on COVID-19 prevention, no perceived COVID-19 infection risk, concerns regarding vaccine safety and effectiveness, and religious and cultural reasons. There is a need for the prioritization of interventions to address vaccine hesitancy and improve vaccine confidence as part of the vaccine roll-out plan. These messaging and/or interventions should be holistic to include the value of other public health measures, be focused and targeted to specific groups, raise awareness on the risks of COVID-19 and effectively communicate the benefits and risks of vaccines.

Indexed as

COVID-19Kenyavaccinationvaccine confidencevaccine hesitancyvaccine hesitancy predictors

Identifiers

PMID34452061
PMCPMC8402839
OpenAlexW3168105798

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.